8-(6-Fluoro-5-methylpyridin-3-yl)-1-(tetrahydro-2H-pyran-4-yl)[1,2,4]triazolo[4,3-a]quinoxaline

ID: ALA4865476

PubChem CID: 164623221

Max Phase: Preclinical

Molecular Formula: C20H18FN5O

Molecular Weight: 363.40

Molecule Type: Unknown

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  Cc1cc(-c2ccc3ncc4nnc(C5CCOCC5)n4c3c2)cnc1F

Standard InChI:  InChI=1S/C20H18FN5O/c1-12-8-15(10-23-19(12)21)14-2-3-16-17(9-14)26-18(11-22-16)24-25-20(26)13-4-6-27-7-5-13/h2-3,8-11,13H,4-7H2,1H3

Standard InChI Key:  KEKDSRDEIVDHBR-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 27 31  0  0  0  0  0  0  0  0999 V2000
   23.3216  -27.6194    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.3204  -28.4430    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.0326  -28.8561    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.0308  -27.2105    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.7435  -27.6158    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.7443  -28.4389    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.4570  -28.8501    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   26.1693  -28.4352    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.4514  -27.2055    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   26.1636  -27.6060    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   26.7633  -27.0522    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   26.4258  -26.3120    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   25.6135  -26.4043    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.0571  -25.8007    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.3090  -25.0169    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.7565  -24.4117    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.9534  -24.5846    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   23.7056  -25.3685    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.2569  -25.9794    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.6117  -27.2111    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.6128  -26.3887    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.9017  -25.9762    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   21.1931  -26.3892    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.1960  -27.2147    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.9035  -27.6194    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.4898  -27.6260    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.4839  -25.9832    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  6  2  0
  5  4  2  0
  4  1  1  0
  5  6  1  0
  6  7  1  0
  7  8  2  0
  8 10  1  0
  9  5  1  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 13  9  1  0
 14 15  1  0
 14 19  1  0
 15 16  1  0
 16 17  1  0
 17 18  1  0
 18 19  1  0
 13 14  1  0
 20 21  2  0
 21 22  1  0
 22 23  2  0
 23 24  1  0
 24 25  2  0
 25 20  1  0
  1 20  1  0
 24 26  1  0
 23 27  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4865476

    ---

Associated Targets(Human)

PRKDC Tchem DNA-dependent protein kinase (1929 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ATR Tchem ATR/ATRIP (56 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ATM Tchem Serine-protein kinase ATM (4198 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MTOR Tclin Serine/threonine-protein kinase mTOR (13850 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PIK3CB Tchem PI3-kinase p110-beta subunit (4044 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 363.40Molecular Weight (Monoisotopic): 363.1495AlogP: 3.68#Rotatable Bonds: 2
Polar Surface Area: 65.20Molecular Species: NEUTRALHBA: 6HBD:
#RO5 Violations: HBA (Lipinski): 6HBD (Lipinski): #RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 2.00CX LogP: 2.01CX LogD: 2.01
Aromatic Rings: 4Heavy Atoms: 27QED Weighted: 0.51Np Likeness Score: -1.32

References

1. Berger M, Wortmann L, Buchgraber P, Lücking U, Zitzmann-Kolbe S, Wengner AM, Bader B, Bömer U, Briem H, Eis K, Rehwinkel H, Bartels F, Moosmayer D, Eberspächer U, Lienau P, Hammer S, Schatz CA, Wang Q, Wang Q, Mumberg D, Nising CF, Siemeister G..  (2021)  BAY-8400: A Novel Potent and Selective DNA-PK Inhibitor which Shows Synergistic Efficacy in Combination with Targeted Alpha Therapies.,  64  (17.0): [PMID:34428039] [10.1021/acs.jmedchem.1c00762]

Source